255 related articles for article (PubMed ID: 34415777)
1. The optimal use of PET/CT in the management of lymphoma patients.
Milgrom SA; Rechner L; Berthelsen A
Br J Radiol; 2021 Nov; 94(1127):20210470. PubMed ID: 34415777
[No Abstract] [Full Text] [Related]
2. PET/CT in Radiation Therapy Planning.
Specht L; Berthelsen AK
Semin Nucl Med; 2018 Jan; 48(1):67-75. PubMed ID: 29195619
[TBL] [Abstract][Full Text] [Related]
3. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
4. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.
Sin KM; Ho SK; Wong BY; Gill H; Khong PL; Lee EY
Clin Imaging; 2017; 42():25-33. PubMed ID: 27875758
[TBL] [Abstract][Full Text] [Related]
5. PET/CT: Radiation Therapy Planning in Head and Neck Cancer.
Eraj S; Sher DJ
PET Clin; 2022 Apr; 17(2):297-305. PubMed ID: 35256302
[TBL] [Abstract][Full Text] [Related]
6. [The role of PET/CT investigation in the management of patients with diffuse large B-cell lymphoma].
Paksi M; Demeter J; Szabó P
Magy Onkol; 2016 Jun; 60(2):108-17. PubMed ID: 27275637
[TBL] [Abstract][Full Text] [Related]
7. Present and future roles of FDG-PET/CT imaging in the management of lung cancer.
Kitajima K; Doi H; Kanda T; Yamane T; Tsujikawa T; Kaida H; Tamaki Y; Kuribayashi K
Jpn J Radiol; 2016 Jun; 34(6):387-99. PubMed ID: 27121156
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.
Qi Z; Gates EL; O'Brien MM; Trout AT
Pediatr Radiol; 2018 Feb; 48(2):196-203. PubMed ID: 29080987
[TBL] [Abstract][Full Text] [Related]
9. The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG).
Mikhaeel NG; Milgrom SA; Terezakis S; Berthelsen AK; Hodgson D; Eich HT; Dieckmann K; Qi SN; Yahalom J; Specht L
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):501-512. PubMed ID: 30763664
[TBL] [Abstract][Full Text] [Related]
10. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
11. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
[TBL] [Abstract][Full Text] [Related]
12.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
13. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
14. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.
Allen-Auerbach M; de Vos S; Czernin J
Radiol Clin North Am; 2008 Mar; 46(2):199-211, vii. PubMed ID: 18619376
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET/CT in the management of lymphomas: current status and future directions.
El-Galaly TC; Villa D; Gormsen LC; Baech J; Lo A; Cheah CY
J Intern Med; 2018 Oct; 284(4):358-376. PubMed ID: 29989234
[TBL] [Abstract][Full Text] [Related]
16. Interim
Garibaldi C; Ronchi S; Cremonesi M; Gilardi L; Travaini L; Ferrari M; Alterio D; Kaanders JHAM; Ciardo D; Orecchia R; Jereczek-Fossa BA; Grana CM
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):555-573. PubMed ID: 28581396
[TBL] [Abstract][Full Text] [Related]
17. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
18. Granulomatous dermatitis: a rare pitfall in lymphoma staging with [
Enke JS; Gäble A; Reitsam NG; Schaller T; Trepel M; Hirschbühl K; Welzel J; Dierks A; Kircher M; Lapa C
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3479-3480. PubMed ID: 37233786
[No Abstract] [Full Text] [Related]
19. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.
Terezakis SA; Schöder H; Kowalski A; McCann P; Lim R; Turlakov A; Gonen M; Barker C; Goenka A; Lovie S; Yahalom J
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):376-83. PubMed ID: 24726287
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging Using PET/CT for Radiation Therapy Planning for Adult Cancers: Current Status and Expanding Applications.
McKay MJ; Taubman KL; Foroudi F; Lee ST; Scott AM
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):783-791. PubMed ID: 30353883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
